Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on chiral induction. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel route for (R)-2-(2,5-difluorophenyl)pyrrolidine avoids noble metals, offering cost-effective API manufacturing solutions.
Novel chiral induction method for Paxlovid intermediate. Reduces cost and improves safety. Reliable supply chain partner for pharmaceutical manufacturing.
Discover how new asymmetric synthesis of (S,S)-2,8-diazabicyclononane reduces costs and steps for moxifloxacin production, ensuring supply chain stability.
Eliminate high-pressure hydrogenation and resolution steps in Moxifloxacin side chain production. Achieve 99%+ ee and 20-30% yield with simplified process. Reduce costs and supply chain risks for API manufacturing.